These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 14717936)
21. Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution. Nasr SH; Valeri AM; Cornell LD; Fidler ME; Sethi S; D'Agati VD; Leung N Clin J Am Soc Nephrol; 2012 Feb; 7(2):231-9. PubMed ID: 22156754 [TBL] [Abstract][Full Text] [Related]
22. [Secondary monoclonal gammopathy after bone marrow autotransplantation as a cause of worse renal function in light chain immunoglobulin deposition disease]. Rekhtina IG; Mendeleeva LP; Stolyarevich ES; Galtseva IV; Povilaitite PE; Biryukova LS Ter Arkh; 2016; 88(6):80-83. PubMed ID: 27296267 [TBL] [Abstract][Full Text] [Related]
23. Autologous transplantation of mobilized peripheral blood CD34+ cells selected by immunomagnetic procedures in patients with multiple myeloma. Abonour R; Scott KM; Kunkel LA; Robertson MJ; Hromas R; Graves V; Lazaridis EN; Cripe L; Gharpure V; Traycoff CM; Mills B; Srour EF; Cornetta K Bone Marrow Transplant; 1998 Nov; 22(10):957-63. PubMed ID: 9849692 [TBL] [Abstract][Full Text] [Related]
24. [High-dose melphalan in patients with multiple myeloma]. Moreau P; Le Bonniec M; Harousseau JL Bull Cancer; 1999 Mar; 86(3):283-8. PubMed ID: 10210762 [TBL] [Abstract][Full Text] [Related]
26. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis. Sanchorawala V; Wright DG; Seldin DC; Dember LM; Finn K; Falk RH; Berk J; Quillen K; Skinner M Bone Marrow Transplant; 2001 Oct; 28(7):637-42. PubMed ID: 11704785 [TBL] [Abstract][Full Text] [Related]
27. Short and long-term outcome of treatment with high-dose melphalan and stem cell transplantation for multiple myeloma-associated AL amyloidosis. Girnius S; Seldin DC; Skinner M; Finn KT; Quillen K; Doros G; Sanchorawala V Ann Hematol; 2010 Jun; 89(6):579-84. PubMed ID: 20012043 [TBL] [Abstract][Full Text] [Related]
28. Autologous transplantation and maintenance therapy in multiple myeloma. Palumbo A; Cavallo F; Gay F; Di Raimondo F; Ben Yehuda D; Petrucci MT; Pezzatti S; Caravita T; Cerrato C; Ribakovsky E; Genuardi M; Cafro A; Marcatti M; Catalano L; Offidani M; Carella AM; Zamagni E; Patriarca F; Musto P; Evangelista A; Ciccone G; Omedé P; Crippa C; Corradini P; Nagler A; Boccadoro M; Cavo M N Engl J Med; 2014 Sep; 371(10):895-905. PubMed ID: 25184862 [TBL] [Abstract][Full Text] [Related]
29. [Optimization of mobilization regimes of blood hemopoietic stem cells in patients with multiple myeloma]. Pokrovskaia OS; Mendeleeva LP; Urnova ES; Gaponova TV; Gribanova EO; Alekseeva IV; Drokov MIu; Kalinin NN; Gretsov EM; Kliasova GA; Savchenko VG Ter Arkh; 2011; 83(7):50-7. PubMed ID: 21894752 [TBL] [Abstract][Full Text] [Related]
30. Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian Multicenter Study. Tribalto M; Amadori S; Cudillo L; Caravita T; Del Poeta G; Meloni G; Avvisati G; Petrucci MT; Pulsoni A; Leone G; Sica S; Martelli M; Tabilio A; Fioritoni G; Majolino I; Mandelli F Haematologica; 2000 Jan; 85(1):52-8. PubMed ID: 10629592 [TBL] [Abstract][Full Text] [Related]
31. [Therapy options in systemic AL-amyloidosis with renal involvement]. Hetzel GR; Schneider P; Mondry A; Heering P; Heyll A; Grabensee B Dtsch Med Wochenschr; 2000 Aug; 125(34-35):997-1002. PubMed ID: 11004911 [TBL] [Abstract][Full Text] [Related]
32. [More than 10 years of complete remission of monoclonal gammopathy of undetermined significance and cessation of light chain deposition disease-associated nephrotic syndrome following treatment with vincristine, adriamycin and high-dose dexamethasone (VAD)]. Adam Z; Nedbálková M; Krejcí M; Pour L; Husek K; Veselý K; Cermáková Z; Krivanová A; Mayer J; Hájek R Vnitr Lek; 2010 Mar; 56(3):240-6. PubMed ID: 20394211 [TBL] [Abstract][Full Text] [Related]
34. Effect of high-dose melphalan and peripheral blood stem cell transplantation on renal function in patients with multiple myeloma and renal insufficiency: a case report and review of the literature. Reiter E; Kalhs P; Keil F; Rabitsch W; Gisslinger H; Mayer G; Worel N; Lechner K; Greinix HT Ann Hematol; 1999 Apr; 78(4):189-91. PubMed ID: 10348151 [TBL] [Abstract][Full Text] [Related]
35. A Phase I dose escalation trial of continuous infusion paclitaxel to augment high dose cyclophosphamide and thiotepa plus stem cell rescue for the treatment of patients with advanced breast carcinoma. Zimmerman TM; Grinblatt DL; Malloy R; Williams SF Cancer; 1998 Oct; 83(8):1540-5. PubMed ID: 9781947 [TBL] [Abstract][Full Text] [Related]
36. Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma. Gertz MA; Lacy MQ; Inwards DJ; Chen MG; Pineda AA; Gastineau DA; Greipp PR; Lust JA; Tefferi A; Witzig TE; Kyle RA; Litzow MR Bone Marrow Transplant; 1999 Feb; 23(3):221-6. PubMed ID: 10084252 [TBL] [Abstract][Full Text] [Related]
37. Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicity. Worel N; Schulenburg A; Mitterbauer M; Keil F; Rabitsch W; Kalhs P; Gisslinger H; Raderer M; Geissler K; Höcker P; Zielinski CC; Oberbauer R; Greinix HT Wien Klin Wochenschr; 2006 Feb; 118(1-2):49-53. PubMed ID: 16489526 [TBL] [Abstract][Full Text] [Related]
38. Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment. Zannetti BA; Zamagni E; Santostefano M; De Sanctis LB; Tacchetti P; Mancini E; Pantani L; Brioli A; Rizzo R; Mancuso K; Rocchi S; Pezzi A; Borsi E; Terragna C; Marzocchi G; Santoro A; Cavo M Am J Hematol; 2015 Jul; 90(7):647-52. PubMed ID: 25858483 [TBL] [Abstract][Full Text] [Related]
39. High-dose chemotherapy with carboplatin, cyclophosphamide and etoposide and autologous transplantation for multiple myeloma relapsing after a previous transplant. Mehta J; Tricot G; Jagannath S; Desikan KR; Siegel D; Singhal S; Munshi N; Vesole D; Mattox S; Bracy D; Barlogie B Bone Marrow Transplant; 1997 Jul; 20(2):113-6. PubMed ID: 9244413 [TBL] [Abstract][Full Text] [Related]
40. High-dose chemotherapy and autologous stem cell transplantation in multiple myeloma: a single institution experience at All India Institute of Medical Sciences, New Delhi, using non-cryopreserved peripheral blood stem cells. Kayal S; Sharma A; Iqbal S; Tejomurtula T; Cyriac SL; Raina V Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):140-7. PubMed ID: 24342104 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]